Stem Cell Therapy for Parkinsons

Stem Cell Infusion Package for Parkinson’s Disease

This advanced regenerative therapy package is designed to support patients with Parkinson’s Disease by targeting neurodegeneration, inflammation, and impaired cellular communication in the central nervous system. The program combines Stem Cell Therapy, Very Small Embryonic-Like Stem Cells (VSELs), and Exosome Therapy to promote neuronal repair, modulate immune responses, and enhance overall brain function.

The treatment includes Stem Cell Infusions using Adipose-Derived, Bone Marrow-Derived, or Umbilical Cord-Derived Mesenchymal Stem Cells, enriched with VSELs for their ability to differentiate into neuronal cells and Exosomes for their signaling molecules that enhance neuroprotection, tissue repair, and cellular communication. Infusions are administered intravenously to allow systemic and targeted effects throughout the central nervous system, supporting the restoration of neural pathways and improving motor function and cognitive resilience.

To enhance neuroregeneration, the program can be combined with specific peptides known to support brain and tissue repair:

• BPC-157: Promotes neurovascular repair, reduces inflammation, and supports neuronal regeneration.

• TB-500 (Thymosin Beta-4): Enhances cellular repair and neuroplasticity.

• Cerebrolysin or N-Acetyl Semax Peptides: Support cognitive function, neuroprotection, and neurotransmitter balance.

This integrative approach provides a comprehensive pathway for slowing neurodegeneration, improving motor and cognitive function, and supporting overall brain health through cutting-edge cellular and peptide therapies.